Axol Bioscience uses iPSCs to build more relevant models of human disease to expand your understanding and de-risk drug development and to support your pursuit of more effective, safer therapies.
Axol Bioscience is committed to being a trusted supplier of human iPSC-derived cells, media products, and related contract services for life science discovery. Their quality policy defines their dedication to performance and quality standards that solidify Axol as a supplier of choice in the iPSC market.
Portfolio
- Cells, media and reagents - axoCells™
- Human-derived cell lines - axoLines™
- Robust models, powered by iPSCs - axoModels™
- Custom laboratory services - axoServices™
axoCells™
The first choice for high-quality, functionally relevant iPSC-derived cells
With over a decade of experience, they developed the manufacturing capabilities to produce high-quality, functional iPSC-derived cells with excellent consistency. Your research can benefit from their quality-focused approach, with their catalog of robust, highly relevant iPSC-derived neurons and cardiomyocytes developed at the ISO 9001:2015-accredited production facility. Axol's leading neuronal cell types include: cortical excitatory neurons, striatal neurons, cortical inhibitory interneurons, microglia, astrocytes, sensory neurons and motor neurons. They also provide high-quality atrial cardiomyocytes and ventricular cardiomyocytes, as well as made-to-order myotubes.
- Neurons and neuroinflammatory cells
- Cardiac cells
axoLines™
Fuel your research with iPSC lines from patient and healthy control donors
Axol has developed a diverse library of over 70 iPSC lines derived from a range of fully-consented patient and healthy donors. With full licenses and a 50:50 split of male:female donors, you can use our axoLines iPSCs for axoServices custom lab services, made-to-order axoCells projects and specific licensing arrangements. Key therapy areas include Alzheimer’s Disease, Parkinson’s Disease, ALS, Huntington’s Disease, Friedreich’s Ataxia and Frontotemporal Dementia.
axoModels™
Work with us to build advanced iPSC-based test systems
Axol is offering their world-leading iPSC expertise to researchers who want to build better human disease models with exciting translational potential. They work collaboratively to build, assess, and execute projects using functional cells derived from patient and healthy control-derived iPSCs, offering a more useful human-relevant test system for research and compound screening. If you’d like to discuss building a robust model for neurodegenerative drug discovery and cardiotoxicity, get in touch to discuss working with us on an axoModels project.
axoServices™
Outsource your iPSC project to the experts
With over a decade of iPSC expertise, you can rely on Axol as your first choice for a professional, QC-rich service delivery and an ongoing collaborative relationship. Take a look at how Axol can do the technical heavy lifting with their full suite of custom lab service projects comprising Reprogramming, Differentiation, Gene Editing, Compound Screening, Multi-Electrode Array and Cell Assays.
